R. Ni

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
R Ni, R. Ni, Ran Ni
Publication record
22 papers · 533 citations · H-index 13

PAPERS

PB0338 The Ideal Acetylsalicylic Acid (ASA) Dose to Combine with P2Y12 Inhibitors: A Volunteer Study
20230 citationsauthor #4
Activated thrombin‐activatable fibrinolysis inhibitor (TAFIa) attenuates fibrin‐dependent plasmin generation on thrombin‐activated platelets
202013 citationsauthor #1
Effect of Different Doses of Acetylsalicylic Acid on the Antithrombotic Activity of Clopidogrel in a Mouse Arterial Thrombosis Model
201814 citationsauthor #1
Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering
201735 citationsauthor #5
Preclinical evaluation of the antithrombotic potential of the most commonly prescribed antiplatelets
20170 citationsauthor #1
Comparison of the effect of dabigatran and dalteparin on thrombus stability in a murine model of venous thromboembolism
201628 citationsauthor #5
Arterial thrombosis is accelerated in histidine-rich glycoprotein deficient mice
20151 citationsauthor #7
Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation
201519 citationsauthor #6
THROMBOSIS AND HEMOSTASIS Arterial thrombosis is accelerated in mice de ﬁ cient in histidine-rich glycoprotein
20151 citationsauthor #6
Arterial thrombosis is accelerated in mice deficient in histidine-rich glycoprotein.
201550 citationsauthor #6
Comparison of the effect of coagulation and platelet function impairments on various mouse bleeding models
201424 citationsauthor #2
Exacerbation of Glycoprotein VI-Dependent Platelet Responses in a Rhesus Monkey Model of Type 1 Diabetes
201315 citationsauthor #5
Exacerbation of GPVI-dependent platelet responses in a rhesus monkey model of type I diabetes
20131 citationsauthor #4
Abnormal megakaryocyte development and platelet function in Nbeal2(-/-) mice.
2013122 citationsauthor #6
Diannexin, an annexin A5 homodimer, binds phosphatidylserine with high affinity and is a potent inhibitor of platelet‐mediated events during thrombus formation
201244 citationsauthor #5
Atorvastatin Delays Murine Platelet Activation In Vivo Even in the Absence of Endothelial NO Synthase
201218 citationsauthor #1
BF061, a novel antiplatelet and antithrombotic agent targeting P2Y12 and PDE
20111 citationsauthor #4
BF061, a novel antiplatelet and antithrombotic agent targeting P2Y12 receptor and phosphodiesterase
201127 citationsauthor #4
The maternal immune response to fetal platelet GPIbα causes frequent miscarriage in mice that can be prevented by intravenous IgG and anti-FcRn therapies.
201192 citationsauthor #11
Monocyte-Derived Microparticles Improve Hemostasis in Factor VIIIDeficient Mice: Exploring the Role of PSGL-1/P-Selectin.
20080 citationsauthor #4
Fibrinogen controls human platelet fibronectin internalization and cell‐surface retention 1
200729 citationsauthor #5
Control of Platelet Fibronectin Internalization and Cell Surface Retention by Fibrinogen: Lessons from Hypofibrinogemic Patients.
20060 citationsauthor #5

TIMELINE

2006 0 citations

2007 29 citations

2008 0 citations

2011 120 citations

2012 62 citations

2013 138 citations

2014 24 citations

2015 71 citations

2016 28 citations

2017 35 citations

2018 14 citations

2020 13 citations

2023 0 citations

R. Ni

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT